Global Radiopharmaceuticals Market Overview And Prospects
Learn about the global radiopharmaceuticals market through The Business Research Company, which provides information on radiopharmaceuticals market size, radiopharmaceuticals market drivers and restraints, radiopharmaceuticals market players, the COVID-19 impact on the radiopharmaceuticals market, and more.
The global radiopharmaceuticals market size is expected to grow from $5.63 billion in 2021 to $5.90 billion in 2022 at a compound annual growth rate (CAGR) of 4.7%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The radiopharmaceuticals market is expected to reach $7.30 billion in 2026 at a CAGR of 5.5%.
The increasing prevalence of cancer and cardiovascular diseases is projected to drive the demand for the radiopharmaceuticals market.
Request A Sample For The Global Radiopharmaceuticals Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3471&type=smp
The radiopharmaceuticals market consists of sales of radiopharmaceuticals and related services by entities (organizations, sole traders, and partnerships) that produce radiopharmaceuticals used in treating cancer, cardiovascular, and other diseases. Radiopharmaceuticals are radioactive compounds administered to the patients, monitored via specific imaging devices, and used for diagnostic and therapeutic purposes.
Global Radiopharmaceuticals Market Segments Include:
By Type: Diagnostic, Therapeutic, Others
By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others
By End-User: Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Cancer Research Institutes, Others
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the radiopharmaceuticals market in 2021.
Many companies are adopting various strategic initiatives such as opening a new manufacturing facility and plant capacity expansion, which is gaining significant popularity in the radiopharmaceuticals market.
TBRC’s radiopharmaceuticals market report covers:
Major Market Players: Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Nordion Inc. (A Subsidiary of Sterigenics International), Mallinckrodt plc, Curium, Eckert & Ziegler, Eli Lilly, Eckert & Ziegler, IBA Group, Merck & Co. Inc., Philips Healthcare, Fujifilm Holding Corporation, Areva Pharma, Navidea Biopharmaceuticals Inc., Actinium Pharmaceuticals Inc., Global Medical Solutions LTD., and Shine Medical Technologies.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)
The Radiopharmaceuticals Global Market Report 2022–Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides radiopharmaceuticals market overviews, analyses and forecasts market size, share, radiopharmaceuticals market players, radiopharmaceuticals market segments and geographies, leading competitor revenues, profiles and market shares.
TBRC’s radiopharmaceuticals market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports From The Business Research Company:
Pharmaceuticals Global Market Report 2022
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read More About Us At https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Found This Article Helpful? Share It On:
